• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

有机改性 MCM 型材料的制备及其在控制阿莫西林释放中的应用。

Organically modified MCM-type material preparation and its usage in controlled amoxicillin delivery.

机构信息

School of Materials and Engineering, Tianjin Key Lab of Fiber Modification & Functional Fiber, Tianjin Polytechnic University, Tianjin 300160, China.

出版信息

J Colloid Interface Sci. 2010 Feb 15;342(2):607-13. doi: 10.1016/j.jcis.2009.10.073. Epub 2009 Oct 31.

DOI:10.1016/j.jcis.2009.10.073
PMID:19948346
Abstract

MCM-41 was grafted with 3-aminopropyl trimethoxysilane (APTMS), 3-chloropropyltriethoxysilane (CPTMS) to give organic group modified samples, and l-tryptophane was covalently immobilized onto organic samples to improve the physicochemical properties of mesoporous silica to controlled amoxicillin delivery. Samples were characterized by X-ray diffraction (XRD), N(2) adsorption-desorption isotherms and Fourier transform infrared (FT-IR) spectroscopy, and characterized results demonstrated that organic groups were successfully grafted onto the samples. The results of amoxicillin release exhibited that 12.9wt% and 33.0wt% impregnated amoxicillin could be released from the post-grafting MCM-41 with APTMS and pure MCM-41 after 24h, however, 41.0wt% impregnated amoxicillin could be released from the post-grafting MCM-41 with CPTMS after 24h. When the samples modified with APTMS and CPTMS were further grafted by l-tryptophane, the slower drug release rate was achieved over samples with l-tryptophane immobilization. The release profiles of all samples indicated that the amoxicillin release was mainly regulated by the diffusion mechanism.

摘要

MCM-41 用 3-氨丙基三甲氧基硅烷 (APTMS)、3-氯丙基三乙氧基硅烷 (CPTMS) 接枝,得到有机基团改性样品,并将 l-色氨酸共价固定在有机样品上,以改善介孔硅的物理化学性质,实现阿莫西林的控释。采用 X 射线衍射 (XRD)、N2 吸附-脱附等温线和傅里叶变换红外 (FT-IR) 光谱对样品进行了表征,表征结果表明有机基团成功接枝到样品上。阿莫西林释放结果表明,接枝 APTMS 的后处理 MCM-41 和纯 MCM-41 在 24h 后可释放出 12.9wt%和 33.0wt%的负载阿莫西林,而接枝 CPTMS 的后处理 MCM-41 在 24h 后可释放出 41.0wt%的负载阿莫西林。当用 APTMS 和 CPTMS 进一步修饰接枝 l-色氨酸的样品时,固定 l-色氨酸的样品达到了更慢的药物释放速率。所有样品的释放曲线表明,阿莫西林的释放主要受扩散机制的调节。

相似文献

1
Organically modified MCM-type material preparation and its usage in controlled amoxicillin delivery.有机改性 MCM 型材料的制备及其在控制阿莫西林释放中的应用。
J Colloid Interface Sci. 2010 Feb 15;342(2):607-13. doi: 10.1016/j.jcis.2009.10.073. Epub 2009 Oct 31.
2
Synthesis, amino-functionalization of mesoporous silica and its adsorption of Cr(VI).介孔二氧化硅的合成、氨基官能化及其对Cr(VI)的吸附
J Colloid Interface Sci. 2008 Feb 15;318(2):309-14. doi: 10.1016/j.jcis.2007.09.093. Epub 2007 Oct 9.
3
Studies on a new carrier of trimethylsilyl-modified mesoporous material for controlled drug delivery.用于控释给药的三甲基硅烷基改性介孔材料新型载体的研究
J Control Release. 2006 Aug 10;114(1):41-6. doi: 10.1016/j.jconrel.2006.05.006. Epub 2006 Jun 19.
4
Hybrid organic-inorganic silica gel carriers with controlled drug-delivery properties.具有控制药物释放性能的杂化有机-无机硅胶载体。
Chemistry. 2009 Nov 9;15(44):12043-9. doi: 10.1002/chem.200900603.
5
Physico-chemical characterization of MCM-41 silica spheres made by the pseudomorphic route and grafted with octadecyl chains.通过拟晶途径制备并接枝十八烷基链的MCM-41二氧化硅球的物理化学表征
J Chromatogr A. 2008 May 16;1191(1-2):125-35. doi: 10.1016/j.chroma.2008.02.026. Epub 2008 Feb 13.
6
Luminescence functionalization of mesoporous silica with different morphologies and applications as drug delivery systems.具有不同形态的介孔二氧化硅的发光功能化及其作为药物递送系统的应用。
Biomaterials. 2008 Feb;29(6):692-702. doi: 10.1016/j.biomaterials.2007.10.019. Epub 2007 Nov 8.
7
Effective controlled release of captopril by silylation of mesoporous MCM-41.通过介孔MCM-41的硅烷化实现卡托普利的有效控释。
Chemphyschem. 2006 Feb 13;7(2):400-6. doi: 10.1002/cphc.200500294.
8
Mesoporous silica material TUD-1 as a drug delivery system.介孔二氧化硅材料TUD-1作为一种药物递送系统。
Int J Pharm. 2007 Feb 22;331(1):133-8. doi: 10.1016/j.ijpharm.2006.09.019. Epub 2006 Sep 19.
9
Mesoporous silica/apatite nanocomposite: special synthesis route to control local drug delivery.介孔二氧化硅/磷灰石纳米复合材料:控制局部药物递送的特殊合成路线。
Acta Biomater. 2008 May;4(3):671-9. doi: 10.1016/j.actbio.2007.11.003. Epub 2007 Nov 26.
10
Synthesis and surface modification of mesoporous mcm-41 silica materials.介孔 mcm-41 硅材料的合成与表面修饰。
J Chromatogr A. 2010 May 14;1217(20):3362-74. doi: 10.1016/j.chroma.2010.03.005. Epub 2010 Mar 10.

引用本文的文献

1
Enhanced Antioxidant Effects of the Anti-Inflammatory Compound Probucol When Released from Mesoporous Silica Particles.抗炎化合物普罗布考从中孔二氧化硅颗粒释放时增强的抗氧化作用。
Pharmaceutics. 2022 Feb 24;14(3):502. doi: 10.3390/pharmaceutics14030502.
2
Virucidal Action Against Avian Influenza H5N1 Virus and Immunomodulatory Effects of Nanoformulations Consisting of Mesoporous Silica Nanoparticles Loaded with Natural Prodrugs.载有天然前药的介孔硅纳米粒子纳米制剂的抗禽流感 H5N1 病毒的病毒杀灭作用和免疫调节作用。
Int J Nanomedicine. 2020 Jul 22;15:5181-5202. doi: 10.2147/IJN.S247692. eCollection 2020.
3
Self-Assembled chitosan/phospholipid nanoparticles: from fundamentals to preparation for advanced drug delivery.
自组装壳聚糖/磷脂纳米粒:从基础到先进药物递释系统的制备。
Drug Deliv. 2020 Dec;27(1):200-215. doi: 10.1080/10717544.2020.1716878.
4
Silica-Polymer Composites as the Novel Antibiotic Delivery Systems for Bone Tissue Infection.二氧化硅-聚合物复合材料作为骨组织感染的新型抗生素递送系统
Pharmaceutics. 2019 Dec 30;12(1):28. doi: 10.3390/pharmaceutics12010028.
5
New Biocompatible Mesoporous Silica/Polysaccharide Hybrid Materials as Possible Drug Delivery Systems.新型生物相容性介孔二氧化硅/多糖杂化材料作为潜在的药物递送系统
Materials (Basel). 2018 Dec 20;12(1):15. doi: 10.3390/ma12010015.
6
Fluorescein isothiocyanate-dyed mesoporous silica nanoparticles for tracking antioxidant delivery.用于追踪抗氧化剂递送的异硫氰酸荧光素染色的介孔二氧化硅纳米颗粒
IET Nanobiotechnol. 2017 Jun;11(4):454-462. doi: 10.1049/iet-nbt.2016.0120.